2,113 reports of this reaction
2.0% of all CLONIDINE reports
#10 most reported adverse reaction
CHRONIC KIDNEY DISEASE is the #10 most commonly reported adverse reaction for CLONIDINE, manufactured by Actavis Pharma, Inc.. There are 2,113 FDA adverse event reports linking CLONIDINE to CHRONIC KIDNEY DISEASE. This represents approximately 2.0% of all 108,277 adverse event reports for this drug.
Patients taking CLONIDINE who experience chronic kidney disease should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CHRONIC KIDNEY DISEASE is a less commonly reported adverse event for CLONIDINE, but still significant enough to appear in the safety profile.
In addition to chronic kidney disease, the following adverse reactions have been reported for CLONIDINE:
The following drugs have also been linked to chronic kidney disease in FDA adverse event reports:
CHRONIC KIDNEY DISEASE has been reported as an adverse event in 2,113 FDA reports for CLONIDINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CHRONIC KIDNEY DISEASE accounts for approximately 2.0% of all adverse event reports for CLONIDINE, making it a notable side effect.
If you experience chronic kidney disease while taking CLONIDINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.